MicroRNA Machine Learning Outperforms Standard Biomarkers in Low-Grade Glioma Drug Response
Researchers demonstrate that machine learning models analyzing microRNA profiles predict temozolomide chemotherapy response in low-grade glioma patients more accurately than ...

